Market Cap 2.52B
Revenue (ttm) 874.84M
Net Income (ttm) 263.86M
EPS (ttm) N/A
PE Ratio 8.04
Forward PE N/A
Profit Margin 30.16%
Debt to Equity Ratio -1.55
Volume 3,960,900
Avg Vol 5,399,970
Day's Range N/A - N/A
Shares Out 254.16M
Stochastic %K 13%
Beta 0.55
Analysts Strong Sell
Price Target $21.60

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
BrexitIsStupid
BrexitIsStupid Jul. 15 at 9:15 AM
$BCRX After hours looked interesting, but at this stage, I really don't know what is going on. I am going to keep holding, like I have done for the last 5 years.
0 · Reply
Paulzk
Paulzk Jul. 15 at 8:57 AM
$BCRX England and Argentina play today 3 PM eastern.
1 · Reply
Paulzk
Paulzk Jul. 15 at 8:55 AM
$BCRX One in five Hispanic business owners in Texas say they’ve had an employee deported in the past year, according to a new survey commissioned by the U.S. Hispanic Business Council The Texas Senate race will be one of the nation’s most watched — and most expensive — this cycle. Early polling shows it in a dead heat: A New York Times/Siena poll released last month showed Paxton and Talarico tied. https://www.politico.com/news/2026/07/12/trumps-deportation-drive-tests-gop-gains-in-texas-00993955
0 · Reply
Paulzk
Paulzk Jul. 15 at 8:46 AM
$BCRX President Trump held a Situation Room meeting Tuesday to discuss a massive offensive in Iran that will be wider in scope than the current strikes around the Strait of Hormuz, three sources with knowledge said. Why it matters: Trump appears willing to escalate the war to cause enough damage that the Iranian regime will open the Strait of Hormuz and accept Trump's nuclear demands. https://www.axios.com/2026/07/15/trump-situation-room-iran-bombing
0 · Reply
Paulzk
Paulzk Jul. 15 at 8:39 AM
$BCRX But will she hold Captain?
0 · Reply
Stash_Cash
Stash_Cash Jul. 15 at 8:36 AM
$BCRX $10.43 at the moment…
0 · Reply
Finger_roll_
Finger_roll_ Jul. 15 at 5:38 AM
$BCRX make me rich bitch!
0 · Reply
Paulzk
Paulzk Jul. 15 at 3:26 AM
$BCRX Biocryst Pharmaceuticals price per share$9.74 XNMS x 1251930 $-0.17 (-1.72%) Bid ARCX 10.16 x 300 Ask ARCX 10.19 x 100 Volume 3,968,215
0 · Reply
Value1008
Value1008 Jul. 15 at 2:16 AM
$BCRX - Some here have mentioned the etf XBI, which holds BCRX shares and which had a green day on Tues after 2 sharp selloff days , and a few folks wondered about the disconnect in share-prices. But look at ETF charts for IBB, PBE (over 3% of which is BCRX shares) and the index $NBI and you'll see chart-action more closely matching the steep sell-off we've seen the past four days for BCRX. In these three latter cases (IBB, PBE, and the $NBI) a sharp sell-off has occurred after reaching an all-time high four trading days ago. They are all testing support at their 20dma after the big run-up. So some people are fuming about the co., the management, etc., but it seems BCRX's recent plunge has more to do with this sudden sharp consolidation pull-back by the biotech segment itself after such a bullish run to new all-time highs. Will the bullish trend continue? I don't have any major reason to doubt it.
3 · Reply
zerotrust77
zerotrust77 Jul. 15 at 1:25 AM
$BCRX oh hurry.. mm’ are on mushrooms again.. lol
1 · Reply
Latest News on BCRX
BioCryst resumed with a Neutral at JPMorgan

2026-07-13T09:50:32.000Z - 2 days ago

BioCryst resumed with a Neutral at JPMorgan


BioCryst price target raised to $14 from $13 at RBC Capital

2026-07-07T11:20:35.000Z - 7 days ago

BioCryst price target raised to $14 from $13 at RBC Capital


BioCryst to present new Orladeyo data at EAACI

2026-06-12T11:15:09.000Z - 4 weeks ago

BioCryst to present new Orladeyo data at EAACI


BioCryst price target raised to $28 from $25 at Citizens

2026-05-07T11:43:06.000Z - 2 months ago

BioCryst price target raised to $28 from $25 at Citizens


BioCryst reports Q1 EPS ($2.98), consensus 11c

2026-05-07T06:49:24.000Z - 2 months ago

BioCryst reports Q1 EPS ($2.98), consensus 11c


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026


BioCryst Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Earnings release: Q1 2026


BioCryst Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Slides: Q1 2026


BioCryst Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Quarterly report: Q1 2026


BioCryst to Present at Upcoming Investor Conferences

Apr 28, 2026, 7:00 AM EDT - 2 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst to Report First Quarter 2026 Financial Results on May 6

Apr 15, 2026, 7:00 AM EDT - 3 months ago

BioCryst to Report First Quarter 2026 Financial Results on May 6


BioCryst price target raised to $14 from $13 at RBC Capital

2026-04-07T15:13:58.000Z - 3 months ago

BioCryst price target raised to $14 from $13 at RBC Capital


BioCryst reports inducement grants under Nasdaq listing rule

2026-03-04T12:08:31.000Z - 4 months ago

BioCryst reports inducement grants under Nasdaq listing rule


BioCryst price target raised to $22 from $21 at Wedbush

2026-03-02T13:53:06.000Z - 4 months ago

BioCryst price target raised to $22 from $21 at Wedbush


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025


BioCryst Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Annual report: Q4 2025


BioCryst Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Earnings release: Q4 2025


BioCryst Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Slides: Q4 2025


BioCryst reports Q4 EPS $1.12 vs (13c) last year

2026-02-26T12:19:23.000Z - 4 months ago

BioCryst reports Q4 EPS $1.12 vs (13c) last year


BioCryst resumed with an Outperform at Evercore ISI

2026-02-18T13:16:21.000Z - 5 months ago

BioCryst resumed with an Outperform at Evercore ISI


BioCryst to Present at Upcoming Investor Conference

Feb 17, 2026, 7:00 AM EST - 5 months ago

BioCryst to Present at Upcoming Investor Conference


BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025


BioCryst Pharmaceuticals Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

BioCryst Pharmaceuticals Quarterly report: Q3 2025


BioCryst Pharmaceuticals Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

BioCryst Pharmaceuticals Earnings release: Q3 2025


BioCryst Pharmaceuticals Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

BioCryst Pharmaceuticals Slides: Q3 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Press release: M&A Announcement


BioCryst Pharmaceuticals Slides: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Slides: M&A Announcement


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 9 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 1 year ago

BioCryst Announces Departure of Dr. Helen Thackray


BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025


BioCryst Pharmaceuticals Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q2 2025


BioCryst Pharmaceuticals Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q2 2025


BioCryst Pharmaceuticals Slides: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q2 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Press release: M&A Announcement


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 1 year ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025


BioCryst Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q1 2025


BioCryst Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q1 2025


BioCryst Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q1 2025


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 1 year ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2024


BioCryst Pharmaceuticals Annual report: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Annual report: Q4 2024


BioCryst Pharmaceuticals Earnings release: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q4 2024


BioCryst Pharmaceuticals Slides: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Slides: Q4 2024


BioCryst Launches ORLADEYO® (berotralstat) in Portugal

Feb 12, 2025, 7:00 AM EST - 1 year ago

BioCryst Launches ORLADEYO® (berotralstat) in Portugal


BrexitIsStupid
BrexitIsStupid Jul. 15 at 9:15 AM
$BCRX After hours looked interesting, but at this stage, I really don't know what is going on. I am going to keep holding, like I have done for the last 5 years.
0 · Reply
Paulzk
Paulzk Jul. 15 at 8:57 AM
$BCRX England and Argentina play today 3 PM eastern.
1 · Reply
Paulzk
Paulzk Jul. 15 at 8:55 AM
$BCRX One in five Hispanic business owners in Texas say they’ve had an employee deported in the past year, according to a new survey commissioned by the U.S. Hispanic Business Council The Texas Senate race will be one of the nation’s most watched — and most expensive — this cycle. Early polling shows it in a dead heat: A New York Times/Siena poll released last month showed Paxton and Talarico tied. https://www.politico.com/news/2026/07/12/trumps-deportation-drive-tests-gop-gains-in-texas-00993955
0 · Reply
Paulzk
Paulzk Jul. 15 at 8:46 AM
$BCRX President Trump held a Situation Room meeting Tuesday to discuss a massive offensive in Iran that will be wider in scope than the current strikes around the Strait of Hormuz, three sources with knowledge said. Why it matters: Trump appears willing to escalate the war to cause enough damage that the Iranian regime will open the Strait of Hormuz and accept Trump's nuclear demands. https://www.axios.com/2026/07/15/trump-situation-room-iran-bombing
0 · Reply
Paulzk
Paulzk Jul. 15 at 8:39 AM
$BCRX But will she hold Captain?
0 · Reply
Stash_Cash
Stash_Cash Jul. 15 at 8:36 AM
$BCRX $10.43 at the moment…
0 · Reply
Finger_roll_
Finger_roll_ Jul. 15 at 5:38 AM
$BCRX make me rich bitch!
0 · Reply
Paulzk
Paulzk Jul. 15 at 3:26 AM
$BCRX Biocryst Pharmaceuticals price per share$9.74 XNMS x 1251930 $-0.17 (-1.72%) Bid ARCX 10.16 x 300 Ask ARCX 10.19 x 100 Volume 3,968,215
0 · Reply
Value1008
Value1008 Jul. 15 at 2:16 AM
$BCRX - Some here have mentioned the etf XBI, which holds BCRX shares and which had a green day on Tues after 2 sharp selloff days , and a few folks wondered about the disconnect in share-prices. But look at ETF charts for IBB, PBE (over 3% of which is BCRX shares) and the index $NBI and you'll see chart-action more closely matching the steep sell-off we've seen the past four days for BCRX. In these three latter cases (IBB, PBE, and the $NBI) a sharp sell-off has occurred after reaching an all-time high four trading days ago. They are all testing support at their 20dma after the big run-up. So some people are fuming about the co., the management, etc., but it seems BCRX's recent plunge has more to do with this sudden sharp consolidation pull-back by the biotech segment itself after such a bullish run to new all-time highs. Will the bullish trend continue? I don't have any major reason to doubt it.
3 · Reply
zerotrust77
zerotrust77 Jul. 15 at 1:25 AM
$BCRX oh hurry.. mm’ are on mushrooms again.. lol
1 · Reply
mikesmith2763
mikesmith2763 Jul. 15 at 1:19 AM
$BCRX did anyone bother to check http://Nasdaq.com lol 😆
1 · Reply
mikesmith2763
mikesmith2763 Jul. 15 at 1:18 AM
1 · Reply
5timechamp
5timechamp Jul. 15 at 12:43 AM
$BCRX who keep accumulating these shares at inflated prices afterhours?.... something is brewing.
1 · Reply
Nibbler
Nibbler Jul. 15 at 12:19 AM
$BCRX Remember that one time we hit $13 AH?
3 · Reply
raylin
raylin Jul. 15 at 12:07 AM
$BCRX To speed up the process, let’s get a lowball offer, say $15, act like we’re doing the analysis, decline, get other BP off the sidelines.
3 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 14 at 11:43 PM
$BCRX normally it is about 2 weeks before so next week
0 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 14 at 11:40 PM
$BCRX no earnings announcement yet…
0 · Reply
ktrader1991
ktrader1991 Jul. 14 at 10:50 PM
$BCRX give us the BO!
0 · Reply
Buysidetrader69
Buysidetrader69 Jul. 14 at 10:32 PM
$BCRX WEDBUSH note hit
1 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 14 at 10:27 PM
$BCRX none of this noise matters, BO soon
0 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 14 at 10:25 PM
$BCRX I like that it’s up but there is not message volume…
0 · Reply
GriZlyBeAr
GriZlyBeAr Jul. 14 at 10:25 PM
$BCRX why is this trending there have been like 5 messages…
0 · Reply